SEC Form 4 · accession 0001861684-26-000006
Vera Therapeutics, Inc. · VERA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph R Young
Officer — SVP, FINANCE, CHIEF ACCT OFFCR
Period of report
Sep 11, 2026
Accepted (ET)
Sep 14, 2026 · 4:28 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001831828
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Sep 11, 2026 | M | 5,000 | $3.9396 | A | 80,754 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $3.9396 | Sep 11, 2026 | M | 5,000 | D | — | Apr 13, 2031 | Class A Common Stock | 5,000 | 33,589 | D |
Explanation of responses
- F11/4 of the shares subject to the option vested on March 9, 2022, and 1/48 of the shares vest monthly thereafter.